These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10732232)

  • 1. [Correction of postischemic reperfusion injury complications by cytoflavin].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Biull Eksp Biol Med; 2000 Feb; 129(2):149-51. PubMed ID: 10732232
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neuroprotective effect of cytoflavin in closed craniocerebral trauma].
    Bul'on VV; Zarubina IV; Kovalenko AL; Alekseeva LE; Sapronov NS
    Eksp Klin Farmakol; 2003; 66(6):56-8. PubMed ID: 14743715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow.
    Bul'on VV; Krylova IB; Evdokimova NR; Kovalenko AL; Alekseeva LE; Sapronov NS
    Bull Exp Biol Med; 2004 Apr; 137(4):411-4. PubMed ID: 15452617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of cytoflavin for correction of complications of myocardial infarction].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis].
    Kosinets VA
    Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antioxidant and membranoprotector treatment of chronic pyelonephritis].
    Gordiushina IV; Savchenko RP; Sukhanov DS; Petrov AIu; Romantsov MG
    Eksp Klin Farmakol; 2011; 74(4):27-30. PubMed ID: 21678656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative experimental study of the influence of drugs that improve brain metabolism (angiogen, cytoflavin) on neuronal apoptosis and function of cerebral cortex during aging].
    Bazhanova ED; Anisimov VN; Sukhanov DS; Teplyĭ DL
    Eksp Klin Farmakol; 2015; 78(2):3-9. PubMed ID: 25898540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Energy corrective and antioxidative actions of cytoflavin during postischemic period of human dermal fibroblasts in vitro].
    Tiuriaeva II; Kuranova ML; Gonchar IV; Rozanov IuM
    Tsitologiia; 2012; 54(6):489-96. PubMed ID: 22997734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protective effect of cytoflavin and its components in mice with acute alloxan intoxication].
    Volchegorskiĭ IA; Rassokhina LM; Ermakova SG; Miroshnichenko IIu
    Eksp Klin Farmakol; 2013; 76(4):26-31. PubMed ID: 23762986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Using cytoflavin for correcting x-ray contrasting agent-induced nephropathy].
    Karpishchenko SN; Zheregelia SN; Glushkov SI
    Eksp Klin Farmakol; 2010 Oct; 73(10):40-2. PubMed ID: 21254514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS].
    Markevich PS; Markevich LB; Plekhanov AN; Kovalenko AL
    Klin Med (Mosk); 2015; 93(6):67-72. PubMed ID: 26495531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma].
    Deriugina AV; Shumilova AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of cytoflavine on bioenergetic processes in the liver after severe limb compression trauma].
    Iunusov IA; Zarubina IV
    Eksp Klin Farmakol; 2009; 72(6):42-5. PubMed ID: 20095400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental evaluation of reamberin and cytoflavin effects on the course and outcome of acute burn injury].
    Zinov'ev EV; Nesterov IuV; Lagvilava TO
    Eksp Klin Farmakol; 2013; 76(4):39-44. PubMed ID: 23762989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of cytoflavin in sports nutrition].
    Kosinets VA; Stolbitskiĭ VV; Shturich IP
    Klin Med (Mosk); 2012; 90(7):56-8. PubMed ID: 23019978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EFFECT OF CITOFLAVIN ON THE PARAMETERS OF LIPID PEROXIDATION IN BLOOD PLASMA OF RATS UNDER COLD STRESS CONDITIONS.].
    Dorovskikh VA; Li ON; Simonova NV; Shtarberg MA
    Eksp Klin Farmakol; 2016; 79(7):29-34. PubMed ID: 29782743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of the antioxidant activity and cardioprotective effect of reamberin and cytoflavin in newborn rats exposed to chronic hemic hypoxia].
    Zadnipryanyi IV; Tretyakova OS; Sataeva TP
    Arkh Patol; 2015; 77(6):39-44. PubMed ID: 26841648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenetic correction of metabolic disturbances in chronic liver affections].
    Romantsov MG; Petrov AIu; Aleksandrova LN; Sukhanov DS; Kovalenko AL
    Antibiot Khimioter; 2012; 57(11-12):33-41. PubMed ID: 23700935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.